Cargando…

Type 2 diabetes mellitus increases the mortality risk after acute coronary syndrome treated with coronary artery bypass surgery

BACKGROUND: Type 2 diabetes mellitus (DM) is a risk factor for cardiovascular diseases and is common among patients undergoing coronary artery bypass grafting (CABG) surgery. The main objective of our study was to investigate the impact of DM type 2, and its treatment subgroups, on short- and long-t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ram, Eilon, Sternik, Leonid, Klempfner, Robert, Iakobishvili, Zaza, Fisman, Enrique Z., Tenenbaum, Alexander, Zuroff, Elchanan, Peled, Yael, Raanani, Ehud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293781/ https://www.ncbi.nlm.nih.gov/pubmed/32534591 http://dx.doi.org/10.1186/s12933-020-01069-6

Ejemplares similares

Revascularization outcomes in diabetic patients presenting with acute coronary syndrome with non-ST elevation
por: Ram, Eilon, et al.
Publicado: (2022)

Impact of type 2 diabetes mellitus on short- and long-term mortality after coronary artery bypass surgery
por: Kogan, Alexander, et al.
Publicado: (2018)

Hypomagnesemia is associated with new-onset diabetes mellitus following heart transplantation
por: Peled, Yael, et al.
Publicado: (2019)

Type 2 diabetes mellitus increases long-term mortality risk after isolated surgical aortic valve replacement
por: Ram, Eilon, et al.
Publicado: (2019)

Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation
por: Ram, Eilon, et al.
Publicado: (2019)

The predictive value of five glomerular filtration rate formulas for long‐term mortality in patients undergoing coronary artery bypass grafting
por: Ram, Eilon, et al.
Publicado: (2022)

Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease
por: Younis, Arwa, et al.
Publicado: (2016)

Surgical treatment on infective endocarditis: impact of diabetes on mortality
por: Kogan, Alexander, et al.
Publicado: (2022)

Frailty and clinical outcomes following aortic valve replacement
por: Ram, Eilon, et al.
Publicado: (2022)

Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial
por: Arbel, Yaron, et al.
Publicado: (2016)

Coronary calcium in patients with and without diabetes: first manifestation of acute or chronic coronary events is characterized by different calcification patterns
por: Shemesh, Joseph, et al.
Publicado: (2013)

Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2
por: Kogan, Alexander, et al.
Publicado: (2023)

Correction: Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2
por: Kogan, Alexander, et al.
Publicado: (2023)

The impact of COVID-19 pandemic on cardiac surgery in Israel
por: Keizman, Eitan, et al.
Publicado: (2020)

The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study
por: Younis, Arwa, et al.
Publicado: (2017)

Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease
por: Klempfner, Robert, et al.
Publicado: (2012)

Coronary artery bypass graft surgery in patients on ticagrelor therapy is not associated with adverse perioperative outcomes
por: Diab, Sammer, et al.
Publicado: (2021)

Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2017)

The predictive value of creatinine clearance for mortality in patients undergoing revascularization
por: Ram, Eilon, et al.
Publicado: (2021)

BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response
por: Peled, Yael, et al.
Publicado: (2021)

Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus
por: Tenenbaum, Alexander, et al.
Publicado: (2003)

Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?
por: Tenenbaum, Alexander, et al.
Publicado: (2008)

Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
por: Tenenbaum, Alexander, et al.
Publicado: (2014)

Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?
por: Fisman, Enrique Z, et al.
Publicado: (2014)

Improved long-term outcomes after heart transplantation utilizing donors with a traumatic mode of brain death
por: Ram, Eilon, et al.
Publicado: (2019)

Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data
por: Tenenbaum, Alexander, et al.
Publicado: (2012)

Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience
por: Peled, Yael, et al.
Publicado: (2022)

Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients – implications for the omicron variant
por: Peled, Yael, et al.
Publicado: (2022)

Correction to: Cardiac surgery in patients with Hemophilia:is it safe?
por: Shalabi, Amjad, et al.
Publicado: (2020)

Renal glucosuria is associated with lower body weight and lower rates of elevated systolic blood pressure: results of a nationwide cross-sectional study of 2.5 million adolescents
por: Fishman, Boris, et al.
Publicado: (2019)

Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment
por: Node, Koichi, et al.
Publicado: (2009)

For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?—A 5‐year follow‐up cohort study
por: Liu, Ru, et al.
Publicado: (2023)

Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)
por: Tenenbaum, Alexander, et al.
Publicado: (2003)

Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Impact of Marital Status on the Outcome of Acute Coronary Syndrome: Results From the Acute Coronary Syndrome Israeli Survey
por: Marcus, Gil, et al.
Publicado: (2019)

Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients
por: Peled, Yael, et al.
Publicado: (2023)

Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia
por: Pasvolsky, Oren, et al.
Publicado: (2015)

Hypertension in cancer patients treated with anti-angiogenic based regimens
por: Wasserstrum, Yishay, et al.
Publicado: (2015)

Nonthyroidal illness syndrome in off-pump coronary artery bypass surgery
por: Caluk, Selma, et al.
Publicado: (2015)

Comparison of Midterm Outcomes Associated With Aspirin and Ticagrelor vs Aspirin Monotherapy After Coronary Artery Bypass Grafting for Acute Coronary Syndrome
por: Björklund, Erik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5455lq8a5f82bk17nerqpbkt7t